Physician profile
Kavitha Gopal
NPI 1467613844
$9,158.22
in general payments reported to CMS, 2019-2025
43 companies · $1,889 in 2025
The $1,889 reported for 2025 was more than what 77% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,014 · 2020: $813 · 2021: $1,365 · 2022: $1,085 · 2023: $1,222 · 2024: $1,770 · 2025: $1,889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,853 · Education: $28.29.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,852.76 |
| Education | $28.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,733.89 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $942.19 | 2019-2025 | Entyvio |
| Janssen Biotech, INC. | $716.65 | 2019-2025 | Tremfya, Stelara, Simponi Aria |
| Madrigal Pharmaceuticals | $439.43 | 2024-2025 | Rezdiffra, Resmetirom |
| Regeneron Healthcare Solutions, INC. | $425.80 | 2022-2025 | Dupixent |
| Braintree Laboratories, INC. | $374.40 | 2019-2022 | |
| Pfizer INC. | $350.80 | 2019-2025 | |
| Ardelyx, INC. | $265.90 | 2023-2025 | Ibsrela |
| Celgene Corporation | $244.36 | 2021-2024 | Zeposia |
| Qol Medical, LLC | $220.96 | 2023-2025 | Sucraid, Sucraid |
| Nestle Healthcare Nutrition INC. | $213.21 | 2020-2023 | |
| Ironwood Pharmaceuticals, INC | $169.63 | 2019-2021 | |
| Gilead Sciences, INC. | $168.93 | 2019-2022 | |
| Genzyme Corporation | $165.95 | 2023-2025 | |
| Fujifilm Healthcare Americas Corporation | $157.81 | 2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kavitha Gopal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.